An unambiguous definition of the term “nanomaterial” is needed for regulatory purposes, a July 2 report from the European Commission’s Joint Research Center concludes. The report suggests that the ...

A recent study found that the majority of interventional phase 3 trials lacked a clear definition of high-risk multiple myeloma, and many patients were missing important data for risk stratification.

Physicians use different definitions of "reasonable medical certainty" when testifying as expert witnesses in child abuse cases. The variability is troubling because it could result in flawed rulings, ...